SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-239558
Filing Date
2023-09-21
Accepted
2023-09-21 16:05:29
Documents
15
Period of Report
2023-09-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d557456d8k.htm   iXBRL 8-K 37894
2 EX-99.1 d557456dex991.htm EX-99.1 8788
6 GRAPHIC g557456dsp00.jpg GRAPHIC 4735
7 GRAPHIC g557456g0921071254041.jpg GRAPHIC 631
  Complete submission text file 0001193125-23-239558.txt   178052

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA reta-20230921.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20230921_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20230921_pre.xml EX-101.PRE 10813
9 EXTRACTED XBRL INSTANCE DOCUMENT d557456d8k_htm.xml XML 3351
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 231269175
SIC: 2834 Pharmaceutical Preparations